The role of immunotherapy in the radical treatment of NSCLC: where are we headed?
Optimizing treatment for renal cell carcinoma with sequential therapies
Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma
The importance of precision immunotherapy: cost, benefit & toxicity
Combination immunotherapy in gastrointestinal cancers: highlights from ASCO 2017